Alisa Wolberg: Thrilled to Have Been Able to Visit the NIH with ASH and Advocate for Science and the Fight 4 Hematology
Alisa Wolberg, Professor at University of North Carolina at Chapel Hill, reposted from ASH on LinkedIn:
”Thrilled to have been able to visit the NIH with ASH last week and advocate for science and the Fight 4 Hematology”
American Society of Hematology (ASH) shared on LinkedIn:
”Last week, ASH leaders went to The National Institutes of Health (NIH) to advocate for blood research.
Drs. Belinda Avalos, Robert Negrin, Jennifer Brown, and Alisa Wolberg met with NIH and NHLBI leaders to discuss critical priorities in hematology.
Key topics included:
- Protecting federal funding for hematology research
- Supporting early-career investigators through the Fight 4 Hematology campaign
- Updates on NIH peer review and other policy changes that impact research and patient care
These conversations are vital for ensuring hematology research continues to advance, patients benefit from breakthroughs, and the next generation of hematologists is supported.
Learn how you can Fight 4 Hematology.”
Stay updated with Hemostasis Today.
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH